Company Valuation: Zydus Lifesciences Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 273,595 451,368 356,774 497,549 1,013,630 1,014,485 - -
Change - 64.98% -20.96% 39.46% 103.72% 0.08% - -
Enterprise Value (EV) 1 329,923 474,956 387,665 503,450 1,010,265 989,472 953,909 925,700
Change - 43.96% -18.38% 29.87% 100.67% -2.06% -3.59% -2.96%
P/E ratio 23.3x 21.2x 7.95x 25.5x 26.4x 21.7x 21.9x 23.2x
PBR 2.64x 3.47x 2.1x 2.84x 5.11x 4.24x 3.64x 3.18x
PEG - 0.3x 0x -0.5x 0.3x 1x -24.21x -3.93x
Capitalization / Revenue 1.92x 2.99x 2.34x 2.89x 5.19x 4.42x 4.14x 3.96x
EV / Revenue 2.31x 3.14x 2.54x 2.92x 5.17x 4.31x 3.89x 3.61x
EV / EBITDA 12x 14.2x 11.6x 14.1x 19x 14.5x 13.9x 14.2x
EV / EBIT 16.2x 18.2x 14.8x 16x 22.3x 16.7x 16x 17x
EV / FCF 20.6x 19.5x 43x 30.4x 43.5x 29.8x 23.8x 23.4x
FCF Yield 4.85% 5.14% 2.33% 3.29% 2.3% 3.35% 4.21% 4.28%
Dividend per Share 2 3.5 3.5 2.5 6 3 5.747 6.456 6.666
Rate of return 1.31% 0.79% 0.72% 1.22% 0.3% 0.57% 0.64% 0.66%
EPS 2 11.49 20.84 43.83 19.3 38.14 46.54 46.12 43.39
Distribution rate 30.5% 16.8% 5.7% 31.1% 7.87% 12.3% 14% 15.4%
Net sales 1 142,531 151,022 152,652 172,374 195,474 229,765 245,114 256,280
EBITDA 1 27,392 33,410 33,407 35,755 53,033 68,134 68,462 65,284
EBIT 1 20,427 26,162 26,277 31,372 45,392 59,397 59,626 54,455
Net income 1 11,766 21,336 44,873 19,603 38,595 46,943 46,494 43,631
Net Debt 1 56,328 23,588 30,891 5,901 -3,365 -25,013 -60,576 -88,785
Reference price 2 267.25 440.90 348.50 491.55 1,007.35 1,008.20 1,008.20 1,008.20
Nbr of stocks (in thousands) 1,023,743 1,023,743 1,023,743 1,012,204 1,006,234 1,006,234 - -
Announcement Date 6/19/20 5/27/21 5/20/22 5/18/23 5/17/24 - - -
1INR in Million2INR
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio (Y) EV / Sales (Y) EV / EBITDA (Y) Yield (Y) Capi.($)
21.22x4.16x14.07x0.57%11.26B
35.91x7.54x26.31x0.81%48.15B
17.41x1.67x7.96x1.53%28.13B
30.93x2.37x12.19x1.28%21.2B
23.38x3.91x15.16x0.78%13.29B
15.15x2.42x8.87x4.39%5.33B
29.18x2.91x15.67x0.19%4.82B
11.49x1.57x6.7x5.22%4.73B
Average 23.08x 3.32x 13.37x percentage-no-prefix 17.11B
Weighted average by Cap. 27.02x 4.34x 16.53x percentage-no-prefix
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock
  4. Valuation Zydus Lifesciences Limited